Rheumatology Flashcards

1
Q

RA involves ___ joints except for ___

A

small joints
DIP
*** NO thoracic/lumbar spine involvement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Synovial fluid of osteoarthritis

A

Low WBC in synovial fluid (Type I fluid, 200-2,000 WBCs), normal viscosity, negative crystals (uric acid, calcium), normal glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Symptoms of OA (3)

A

i. Pain with activity, crepitus, deformity, limited ROM
ii. Pain at END of day
iii. Non-inflammatory pain = worse with use, worse at end of day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

X rays of OA

A

asymmetric joint space loss, osteophytes, less cartilage, bony cysts, bone sclerosis

  • Heberden’s (distal interphalangeal joints) and Bouchard’s (proximal phalangeal joints) nodes
      1. Hard, nontender, not warm
      2. Formation of calcified spurs of articular cartilage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Risk factors of OA

A

age, obesity, genetics, prior trauma/surgery to joint, family history

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pathology of OA

A

Imbalance between destruction/production of articular cartilage by chondrocytes - More destruction in late disease

Cartilage is AVASCULAR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

4 things made my chondrocytes in cartilage

A

collagen II, proteoglycans, aggrecan, hyaluronic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Synovium contains (3)

A

i. Cytokines (IL-1, TNF)
ii. Growth factors (TGF-B, BMP)
iii. Enzymes (MMPs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Degradation of cartilage in OA

five associated factors

A

catabolic - chondrocytes/synovium release pro-inflammatory cytokines to degrade ECM

i. MMPs (13, 3)
ii. ADAMTS
iii. Cytokines (IL-1, TNF)
iv. NO
v. Prostaglandins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Synthesis of cartilage

5 associated factors

A

anabolic

i. Collagen II
ii. Aggrecan
iii. Link protein
iv. Inhibitory cytokines (IL-4, IL-10, IL-13)
v. Growth factors (TGF-B, BMP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Treatment of OA

A

NSAIDS, topical NSAIDS, hyaluronic acid matrix injections, analgesics (opioid and nonopioid), PT, surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

RA manifestations (6)

  • what joint is spared?
  • symmetric or asymmetric?
  • what two kinds of classic deformities?
  • what kinds of extra-articular manifestations?
  • morning or night stiffness?
A
  1. Peripheral, systemic, inflammatory synovitis
  2. Cartilage/bone destruction, and joint deformities
    a. Erosions into the joint space
  3. PIPs and MCPs abnormal (proximal) - warm, tender, soft (spongy/boggy)
    a. DIPs and thumb joint often spared
    b. Cervical spine commonly involved (C1-2)
    c. Often symmetric

4.Swan neck and boutonniere deformity

  1. Fewer extra-articular manifestations
    a. Episcleritis (in eye)
    b. Pulmonary nodules

6.MORNING stiffness, limited ROM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Serologic findings of RA (5)

A
  1. Rheumatoid Factor present in 85%
    a. IgM anti IgG (binds Fc portion of IgG)
  2. Elevated ESR or CRP
  3. Anemia, hypergammaglobulinemia
  4. Anti-cyclic citrullinated peptide (CCP) antibodies present
  5. “Seropositive” when CCP and RF both present
    a. Prognostically bad when both present
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Synovial fluid RA

A

inflammatory (> 2000 WBC, neutrophils)

-Low complement and glucose levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

XRAY RA (3)

A
  1. Soft tissue swelling
  2. Erosions in marginal distribution
  3. Symmetric loss of joint space
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Risk factors RA

A

genetics, smoking, infections, environmental factors, microbiome, hormones

Risk alleles: encode enzymes/inflammatory pathways we can block

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Risk Alleles in RA (2)

A
  1. HLA-DR4

2. HLA-DR-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

HLA-DR4 and HLADR-1

A

biggest risk alleles

Antigen ingested by APC → digest in endosome → goes through golgi and becomes citrullinated (BAD) → put on MHC II - in hypervariable region (QKRAA sequence motif) of HLA-DR4/1 groove (aka SHARED EPITOPE) → presented to T cell

T cell → RF production, CCP, and autoimmunity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

RF B cells

A

Can secrete RF or have RF receptors on surface

  • RF-IgG immune complexes are PATHOGENIC
  • RF not ver specific for RA
  1. Results in classical complement activation
  2. RF and complement can deposit in joint, sclera, lungs, skin and cause problems
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Late stage RA: synovial tissue

cell types present (4)

A

synovial hyperplasia

1) CD4 T cells
2) Macrophages
3) B cells
4) Th17 cells
5) DCs

NO PMNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Late stage RA synovial tissue:

macrophages –> ?
B cells –> ?
Th17 cells –> ?

A

macrophages –> cytokine cascade (IL-1, IL-6, TNFa, MMPs)

B cells –> activated by T cells, RF and anti-CCP abs –> complement

Th17 cells –> IL-17

CD4+ memory T cells –> modulate and amplify local immune response through antigen recognition + IL-6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Pannus

A

Present in Late stage RA

organized mass of granulation tissue

Consists of: macrophages, T cells, B cells, fibroblasts

Arises due to inflamed synovium and cytokines
→ Bony destruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Extra-articular disease in RA is mediated by…

A

complement pathway destruction

-Complement induced vasculitis and Rheumatoid nodule formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

You can get hyperuricemia with…

A

overproduction

underexcretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Increased production of urate typically due to super-activity in __________ or deficiency in ___________

A

superactivity of PRPP (phosphoribosyl-pyrophosphate) synthetase

OR

deficiencies in HGPRT (hypoxanthine-guanine phosphoribosyltransferase)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Increase production of urate defined as urinary excretion of UA > _______

A

750 mg per 24 hours

Overproduction gout is usually genetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Lesch-Nyhan

A

complete deficiency of HGPRT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Decreased excretion of urate defined as urinary excretion of UA less than _______

A

750 mg per 24 hours

MAJORITY of primary gout patients are UNDER EXCRETORS of uric acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Uricase

A

enzyme that oxidizes uric acid to allantoin (highly soluble)

Humans DO NOT have this enzyme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

MSU crystals are formed when…

what decreases urate solubility?

A

supersaturation of uric acid (hyperuricemia)→ gout crystal formation

Decreased urate solubility with: low temp, dehydration, trauma, low pH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

MSU crystals cause an inflammatory response. This can involve…(4)

A

1) inflammatory response PMN dependent
2) TLR 2 and 4 (on PMN)
3) NLRP3 Inflammasome (in PMN) –> IL-1B production
4) activate complement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

IL-1 + TNF –>

A

endothelial activation (allowing PMN infiltration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

MSU crystals bind TLR 2 and 4 on PMNs –> ?

A

intracellular cascade that causes GENE UPREGULATION

→ critical to inflammatory response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

MSU crystals engage _______ –> NLRP3 inflammasome activated in PMN –> release of what cytokine?

A

caspase-1

IL-1B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

MSU crystals can also be coated with IgG. This results in…

A

→ promotion of phagocytosed into PMN

IgG binding MSU crystals in NONSPECIFIC anti-crystal antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

___________ coating of crystals inhibits phagocytosis and cellular response

A

Apolipoprotein-B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Acute Gouty Arthritis

A
  • abrupt onset
  • VERY painful, warm, red swollen joint

-MTP joint of great toe most often involved, also ankles, heels, knees, wrists, fingers, and elbows
[Podagra = painful condition of big toe]

  • Spontaneously resolve over 3-10 days
  • Predilection for cooler, acral sites (MSU crystals have lower solubility)

ASYMMETRIC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Synovial fluid in gout (3)

A

MSU crystals present (needle-shaped, negatively birefringent)

Inflammatory - 2,000-100,000 WBCs (neutrophils predominantly)

Elevated ESR (test of inflammation)

39
Q

Gout vs. pseudogout

A

Gout = MSU crystal

  • Process of supersaturation
  • Diet, pH and temperature are all variables - DO NOT matter in pseudogout
  • Tissue deposition of monosodium urate (MSU) crystals due to hyperuricemia (MSU supersaturation of extracellular fluids)

Psuedogout = CPPD crystals (calcium crystals)

  • MTP rarely involved
  • Usually in women and older patients
  • due to abnormal pyrophosphate metabolism
40
Q

Calcium Phosphate Dihydrate Deposition Disease (psuedogout)

Pathology

A
  • CPDD crystals are rhomboid-shaped, blue, positively birefringent - PREFORMED, NOT SOLUBILTY EVENT
  • due to abnormal pyrophosphate metabolism
41
Q

What causes pseudogout?

A

Due to abnormal pyrophosphate metabolism

1) ANKH gene mutation: membrane transporter of pyrophosphate in chondrocytes → CPPD crystal formation due to excess PPi being pushed out of chondrocytes
2) NTP pyrophosphohydrolase defect that converts NTP –> NMP + Pi –> more Pi extracellularly

Too much extracellular pyrophosphate precipitates with calcium → CPPD

42
Q

“Shedding Phenomena” (aka strip mining)

A

preformed CPPD crystals released into synovial fluid

43
Q

Allopurinol and febuxostat are…

A

Xanthine Oxidase Inhibitor

Anti-hyperuricemic medications

decrease uric acid production

44
Q

Risk factors for gout

A

dietary obesity, genetic factors, HTN, certain meds

Dairy is protective!

45
Q

Large and medium-vessel vasculitis pathophysiology

A

infiltration of WBCs through vessel wall, associated with granuloma, disruption of elastic lamina, thickening of intima → obliteration of vessel lumen (same as medium vessel)

46
Q

Small-vessel vasculitis pathophysiology

A

typically leukocytoclastic vasculitis

47
Q

Giant cell arteritis

A

Large-vessel vasculitis

temporal arteries or vessels originating from aortic arch → Temporal headache, scalp tenderness, visual loss

48
Q

Takayasu’s arteritis

A

large-vessel vasculitis

49
Q

ANCA positive vasculitis

A
  • Granulomatosis with polyangiitis (GPA)
  • Eosinophilic granulomatosis with polyangiitis
  • Microscopic polyangiitis (MPA)
50
Q

Granulomatosis with polyangiitis (GPA)

A

Effects upper respiratory tract, lungs, kidneys

Associated with serum cytoplasmic-ANCA (c-ANCA)

51
Q

Microscopic polyangiitis (MPA) are positive for serum ____________

A

Serum perinuclear-ANCA (p-ANCA)

52
Q

Clinical features of vasculitis

A
  • Skin lesions, palpable purpura
  • Fever, anorexia, weight loss, weakness, fatigue
  • MSK symptoms: arthralgias, arthritis myalgias, peripheral neuropathy
  • Inflammatory infiltration into nerve and nerve blood supply → neuropathy (Mononeuritis multiplex)
  • Glomerulonephritis (IC deposition in glomeruli) → protein in urine
53
Q

Lab findings of vasculitis (8)

A
  • Anemia, thrombocytosis
  • Low albumin
  • Elevated ESR and CRP
  • Polyclonal gammopathy
  • Elevated liver enzymes (AST, ALT)
  • Low complement (consumed by immune complex formation, classical complement pathway)
  • Cryoglobulins
  • Detection of serum autoantibodies (RF, ANA, ANCA)
54
Q

Different immunopathogenic mechanisms that mediate vasculitis (5)

A

1) Immune Complexes
2) Anti-neutrophil Cytoplasmic Antibodies (ANCA)
3) Anti-endothelial antibodies
4) T cell dependent mediated endothelial cell injury
5) Infection of endothelial cells

55
Q

Immune complex mechanisms of vasculitis

A

Deposition of circulating ICs at the vascular endothelium → activation of complement and attraction of PMNs

  • Deposition in skin, kidneys, nerves, etc.
  • Results in decreased complement levels
  • Antigen can be: drugs, bugs, connective tissue disease, malignancy
56
Q

mechanism of ANCA in vasculitis

A

ANCA = abs to antigens found in the cytoplasm of neutrophils

Inflammatory cytokines → activated PMNs that express PR3 or MPO on cell surface

ANCA binds neutrophil surface → further neutrophil activation and binding to vascular endothelial cells → vascular damage

-Role in amplifying inflammatory vascular response

57
Q

Types of ANCA (2)

A

1) cytoplasmic-ANCA

2) perinuclear-ANCA

58
Q

c-ANCA

stains what?
associated with what disease?

A

cytoplasmic staining, binds proteinase 3 (PR3) in primary granules of PMNs

→ Granulomatosis with polyangiitis (GPA)

Effects Lung, kidney, mononeuritis

59
Q

p-ANCA

stains what?
associated with what disease?

A

perinuclear staining, binds MPO in primary granule of PMN

→ Microscopic polyangiitis (MPA)
Effects Kidney

60
Q

Clinical features of Polymyositis and Dermatomyositis (4)

A

1) Chronic muscle weakness (symmetric proximal muscle weakness, problem standing, climbing stairs, etc.)
* *WEAKNESS MORE THAN PAIN**

2) Inflammation of muscle tissues by chronic inflammatory cells
3) Skin disease
4) Constitutional symptoms

61
Q

Lab findings of Polymyositis and Dermatomyositis

A

1) Elevated muscle enzymes (CPK, aldolase, AST, ALT, LDH)
2) Autoantibodies (ANAs, MSA, MAA)
3) Elevated ESR
4) EMG findings (myopathic findings)
5) MRI findings (muscle inflammation, edema, fibrosis, calcinosis)

62
Q

EMG findings of PM/DM (3)

A

myopathic findings

1) Decreased amplitude of motor unit APs
2) Spontaneous fibrillations
3) Increased insertional activity

63
Q

Anti-synthetase Syndrome

  • type of antibody?
  • presentation
A

Anti-synthase abs: directed against Anti-histidyl-tRNA synthetase (aminoacyl-tRNA synthetase)

-anti-Jo-1 antibody

PM or DM presenting with **Interstitial lung disease (very SOB, new onset cough)

NOT PATHOLOGIC OR MYOTOXIC ANTIBODIES

64
Q

Biopsy findings in PM

A

PM → CD8+ T cells, macrophages

*CTL mediated muscle injury

65
Q

Biopsy findings in DM

A

DM → CD4+ T cells, B cells, macrophages, dendritic cells)
Concentrated in perivascular regions of muscle

*Complement mediated vasculopathy

66
Q

Polymyositis

Distribution?
Inflammatory infiltrate?
Rash?

A

Endomysial distribution of inflammatory cells surrounding and invading muscle fibers (more generalized inflammation)

CD8+ T cells

No rashes

67
Q

Dermatomyositis

Distribution?
Inflammatory infiltrate?
Rash?

A

Perivascular and perifascicular inflammatory infiltrate

CD4+ T cells

Skin RASHES present

Rashes = Gottron’s, Heliotrope, Shawl, Gun Holster

More atrophy of muscles

68
Q

PM and DM may be triggered by…

A

Viral infections

  • Disease pattern is seasonal
  • Elevated IFN
69
Q

Ankylosing Spondylitis

Onset?

Pain - when, where, what kind, what makes it better?

A

1) Onset YOUNG (16-40yrs)
2) Axial
3) Morning stiffness
4) improved with exercise
5) Effects Sacroilitis, entheses

70
Q

Lab findings in Ankylosing Spondylitis

elevated _______
no _____ or ______

A

Elevated ESR
no RF, no ANA (seronegative)
(NO ANTIBODIES)

71
Q

Xray findings in Ankylosing Spondylitis (3)

A
  • Spinal fusion (bambooing of spine)
  • peripheral arthritis involving large joints
  • asymmetric distribution
72
Q

Ankylosing Spondylitis, reactive arthritis, psoriatic arthritis all associated with what risk allele?

A

HLA-B27

73
Q

HLA-B27 people are genetically susceptible to develop disease when exposed to _________ such as ____________

A

environmental trigger

salmonella, shigella, yersinia, campylobacter, chlamydia* can induce reactive arthritis in 20% of B27+ individuals

74
Q

HLA-B27 theories (4)

A

1) Arthritogenic peptide hypothesis
2) Molecular mimicry
3) Free heavy chain hypothesis
4) Unfolded protein hypothesis

75
Q

Arthritogenic peptide hypothesis

A

specific microbial peptides bind HLA-B27 → present to CD8+ CTLs*

76
Q

Molecular Mimicry

A

autoreactivity to self antigens due to similarity between epitopes on antigen and HLA-B27 molecule

77
Q

Free heavy chain hypothesis

A

formation of stable homodimers of HLA-B27 heavy chains* without antigen in a cell

→ activate NK cells* via interaction with Killer Cell Immunoglobulin-like Receptor (KIR)*

78
Q

Unfolded protein hypothesis

A

HLA-B27 has propensity to misfold in ER → unfolded protein stress response → inflammatory cytokines* (IL-23) → upregulate Th17*

79
Q

Seronegative spondyloarthropathies pathology (2)

Synovium has increased ________ (cyotkine)

A

Enthesis: inflammation of ligament, tendon, and fibrous structures as they insert into bone

Synovium has increased TNFa

No RF or ANA antibodies

80
Q

Types of spondyloarthropathy (4)

A

1) Ankylosing Spondyloarthritis
2) Psoriatic arthritis
3) IBD (Crohn’s, UC)
4) Reactive Arthritis (STDs, Cdiff, etc.)

81
Q

RA vs. Spondylo

1) symmetric or asymmetric?
2) peripheral or axial?
3) big or small joints?
4) antibodies?
5) where does it occur?
6) gender?

A

RA:

1) symmetric
2) peripheral
3) small joints
4) RF+, CCP+
5) synovitis
6) female 2:1

Spondylo:

1) asymmetric
2) axial
3) BIG joints
4) no abs (seronegative)
5) occurs at entheses
6) male

82
Q

Systemic Lupus Erythematosus Symptoms and clinical features (6)

A
  • Malar rash
  • Discoid rash
  • photosensitivity
  • arthritis
  • 9:1 females (young)
  • affects kidneys (Type III immune complex deposition or type II ab against specific cell/tissue
83
Q

Organ specific immunity

A

Immune response against single/restricted set of autoantigens within a given organ → autoimmune destruction of only those organs

84
Q

Systemic Autoimmunity

A

Immune response against multiple auto-antigens → disease affects multiple organs with immune complexes and direct immune attack

e.g. SLE

85
Q

Genetics of SLE

A

Multigenic disease with a major MHC contribution

-HLA-DR3, C4 Null Alleles

86
Q

Pathophysiology theories of SLE (5)

A

1) Sex hormones (disease accelerating effect of estrogen, protective effect of androgens)
2) Sun exposure
3) Type II antibody-mediated disease
4) Type III immune complex disease
5) BOTH innate and adaptive immune systems involved

87
Q

SLE has antibodies to…

A

nuclear component (ANA) –> markers of disease, causes of tissue damage (LUMPY BUMPY)

-anti-dsDNA antibodies

> 95% of SLE patients have ANA, but ANA is NOT specific to SLE

88
Q

T cell involvement in pathogenesis of SLE (2)

A

Recognition of self as foreign –> T AND B cell response

Antibody responses towards autoantigen are antigen driven and require CD4+ T cells

Loss of T cell tolerance for self –> activation of autoreactive B cells

89
Q

Antiphospholipid antibodies act to increase ___________

A

clotting

90
Q

Vasculitis T cell mediated endothelial injury

A

HLA-DR4 and giant cell arteritis; suggests ANTIGEN-DRIVEN vascular inflammation

91
Q

The worst symptoms of PM and DM is ________ and it occurs in 60% of patients.

A

Interstitial lung disease

92
Q

Reactive arthritis often occurs with a history of __________

A

infectious diarrhea or urethritis

93
Q

Reactive arthritis is asymmetric, oligoarticular and _________ arthritis. Can include _________ and _________

A

Lower extremity

Dactylitis (sausage fingers)
Reiter’s Syndrome (can’t see, can’t pee, can’t climb a tree)

94
Q

Chance of developing AS:

______ if HLA-B27 +
______ if HLA-B27 + and 1st degree relative with AS

A

2%

20%